Although its use was once shrouded by taboo and prohibition, the tide is now changing for medicinal cannabis. The increase in the legalisation of cannabis throughout the world has piqued consumer interest, and driven growth in research and development. Indeed, such research has enabled consumers to look beyond the assumption that all forms of cannabis will make them “high” – an assumption attributed to tetrahydrocannabinol (THC), the psychoactive compound within ...
Read More

Medical Cannabis Network sent journalist Stephanie Price to see for herself the enormous scale of the project and the preparation processes that European medical cannabis companies in Portugal are required to meet at each stage of a project. Stephanie, who spent a couple of days with the Symtomax team onsite in Beja, Portugal, to see and understand the complex processes necessary in applying for a medical cannabis cultivation license in ...
Read More

2020 is looking to be a remarkable year for medicinal cannabis. The sheer amount of both research and new applications we are witnessing looks set to make the coming decade a cultural turning point for cannabis, in all its forms. Symtomax asks the question: where are the most groundbreaking advancements happening? Moreover, where should we as an industry be directing our innovation for the greatest benefit to the community? Cultivation ...
Read More

With the upcoming inspection by Infarmed on May 5th and 6th progress on Europe’s largest medical cannabis cultivation site in the heart of the Alentejo region of Portugal is on schedule. With the facility concrete levelling now completed, leading specialist company AgroPharm who are undertaking the engineering project, and have been involved from the initial planning to the greenhouse building, will also be undertaking the watering, hydroponics, and artificial illumination ...
Read More